Dartmouth researchers have found a machine learning method that can predict the likelihood that a high-risk type of breast lesion is cancerous, potentially saving some women from unnecessary surgeries and overtreatment.
Post Tagged with: "breast cancer"
A newly published collaborative national study finds that most women with two or three sites of cancer in a single breast can successfully complete breast conservation therapy rather than mastectomy.
A research team at The Dartmouth Institute for Health Policy and Clinical Practice has received a $2 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to conduct a research project that is likely to change the way women and their doctors make decisions about breast cancer surgery.
Dartmouth SYNERGY Clinical and Translational Science Institute has appointed Richard J. Barth, Jr., MD, as the first recipient of its SYNERGY Clinician-Entrepreneur Fellowship (S-CEF). The S-CEF will provide Dr. Barth with resources and dedicated time to develop and study the commercial potential of a new system to improve certain types of breast cancer surgery.
Thanks to a $100,000, two-year grant from the Mary Kay Foundation, Geisel researchers are launching a study to identify the biological mechanisms that allow clinically dormant ER+ breast cancer cells to survive anti-estrogen therapy.
U.S. News & World Report via Health Day News – Cites a study conducted by researchers from Dartmouth and Harvard, which found that regular mammogram screening for breast cancer might be causing “widespread overdiagnosis.” The study found that the death rate from breast cancer did not appear to drop in the face of increased mammogram rates.
Los Angeles Times – Additional coverage on a study by researchers from the Dartmouth Institute for Health Policy and Clinical Practice at Geisel and Harvard, which found that mammogram screening tests aren’t working as hoped. Instead of preventing deaths by uncovering breast tumors at an early, more curable stage, screening mammograms have mainly found small tumors that would have been harmless if left alone.
A recent study evaluating HER2 testing in a large cohort of women with breast cancer found important limitations in the conventional way HER2 testing is performed in the U.S. and internationally.
A Dartmouth researcher has found that reducing carbohydrate intake could reduce the risk of breast cancer recurrence among women whose tumor tissue is positive for the insulin-like growth factor 1 (IGF1) receptor.
Dartmouth researchers have found that the anxiety experienced with a false-positive mammogram is temporary and does not negatively impact a woman’s overall well-being.